Global Ureteral Stents Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

• June 2022, Boston Scientific has been recognized with a Bronze Edison Award in the Science and Medical category for its Tria Ureteral Stent, the first stent made with a proprietary surface technology designed to provide protection against the accumulation of both urine calcium and magnesium salt deposits.

• May 2022, The United States Food and Drug Administration granted 510k clearance for a novel urinary stent developed by Dean Secrest and Lee Ponsky, MD, Chair of the Department of Urology and Leo and Charlotte Goldberg, Chair in Advanced Surgical Therapies at University Hospitals (UH) in Cleveland.

The Global Ureteral Stents Market is segmented to offer an in-depth analysis of the factors influencing its growth and expansion. The segmentation by Product highlights the different types of ureteral stents available, including double-J stents, pigtail stents, and others designed to address specific patient needs and medical conditions. Each product type offers unique features suited for various surgical and therapeutic applications, impacting market trends and preferences among healthcare providers.

The Raw Material segmentation provides insights into the materials used in manufacturing ureteral stents. Common raw materials include silicone, polyurethane, and other biocompatible polymers. The choice of material affects factors such as biocompatibility, flexibility, and durability, which are critical for patient safety and the efficacy of stent placement. This segmentation helps identify which materials are driving innovation and meeting evolving medical requirements.

The Application segmentation focuses on the therapeutic uses of ureteral stents, which range from managing ureteral obstructions, post-surgical drainage, and preventing complications related to kidney stones or urinary tract surgeries. Each application has distinct demand patterns, driven by the frequency of related procedures and patient needs. Understanding the application breakdown allows for better predictions regarding market growth and the types of stents that will be in higher demand.

The End Users segmentation explores the healthcare settings where ureteral stents are most commonly utilized. This includes hospitals, outpatient surgical centers, specialty clinics, and academic research institutions. Hospitals often account for a significant share due to their comprehensive surgical capabilities and patient care services. Outpatient centers and specialty clinics are seeing increased use of ureteral stents as outpatient procedures become more common, promoting faster recovery times and reduced healthcare costs.

Lastly, the Geography segmentation sheds light on regional differences in market behavior and adoption rates. Different regions, such as North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa, exhibit varied growth due to factors like healthcare infrastructure, demographic trends, and disease prevalence. For example, North America and Europe are often characterized by advanced medical facilities and higher rates of complex urological procedures, while regions in Asia-Pacific may show rapid growth driven by improving healthcare access and increasing patient awareness.

Global Ureteral Stents Segment Analysis

In this report, the Global Ureteral Stents Market has been segmented by Product, Raw Material, Application, End Users, and Geography.

Global Ureteral Stents Market, Segmentation by Product

The Global Ureteral Stents Market has been segmented by Product into Double Pigtail Stents, Open-End Stents, Closed-End Stents and Others.

Double pigtail stents are among the most commonly used ureteral stents. These stents feature a curled or pigtail shape at both ends, which helps secure them in place within the urinary tract. They are designed to provide stability and prevent migration, making them suitable for various urological conditions, such as kidney stones and urinary obstruction. The popularity of double pigtail stents can be attributed to their effectiveness in maintaining urinary flow while minimizing patient discomfort.

Open-end stents are another essential product segment in the ureteral stents market. Unlike double pigtail stents, open-end stents have one end that remains open, allowing urine to flow freely from the kidney to the bladder. This design helps reduce the risk of blockages caused by debris or blood clots, ensuring continuous drainage and preventing complications. Open-end stents are commonly used in cases of ureteral strictures, ureteral injury, or after urological surgeries to promote healing and prevent urinary retention.

Closed-end stents, on the other hand, feature a sealed or capped end, which prevents urine from flowing out through that end. These stents are often preferred in situations where backflow of urine into the kidney needs to be minimized, such as in cases of vesicoureteral reflux (VUR) or when managing urinary fistulas. Closed-end stents help maintain urinary tract integrity and prevent reflux-related complications, providing patients with effective symptom relief and improving overall quality of life.

The market for ureteral stents also includes other specialized types catering to specific clinical needs. These may include modified designs, coatings for reduced encrustation, or stents with antimicrobial properties to prevent infections. As technology continues to advance and clinical insights evolve, the market is likely to witness further innovation in ureteral stent design and functionality, driving improvements in patient outcomes and treatment efficacy.

Global Ureteral Stents Market, Segmentation by Raw Material

The Global Ureteral Stents Market has been segmented by Raw Material into Silicone, Polymer, Metal and Others.

Silicone-based ureteral stents dominate a substantial portion of the market. Silicone offers desirable characteristics such as biocompatibility, flexibility, and inertness, making it an ideal choice for medical devices. These stents are widely used in various urological procedures due to their ability to conform to the shape of the urinary tract, reducing discomfort for patients and ensuring optimal drainage.

Polymer-based ureteral stents have also gained traction in the market. These stents are typically made from materials like polyurethane or polyethylene. Polymer stents offer advantages such as durability, resistance to encrustation, and ease of insertion. They are particularly suitable for long-term stenting applications where biocompatibility and stability are crucial factors.

Metallic ureteral stents, although less common compared to silicone and polymer stents, serve specific clinical needs. These stents are often used in cases where additional support and rigidity are required, such as in patients with strictures or complex anatomical structures. Metal stents are known for their strength and longevity, but their use may be limited by concerns regarding tissue irritation and potential migration.

Other raw materials used in ureteral stents include biodegradable polymers and composite materials. Biodegradable stents offer the advantage of gradual degradation, eliminating the need for a secondary removal procedure. Composite materials, combining different properties of various raw materials, aim to optimize stent performance and patient outcomes.

Global Ureteral Stents Market, Segmentation by Application

The Global Ureteral Stents Market has been segmented by Application into Ureteroscopy, Lithotripsy, Percutaneous Nephrolithotomy, Kidney Transplantation, Urinary Incontinence and Others.

One of the key segments driving this growth is ureteroscopy. Ureteroscopy involves the use of a small, flexible scope to access and treat urinary tract conditions such as kidney stones. Ureteral stents play a crucial role in this procedure by facilitating the passage of urine and preventing complications like ureteral stricture or blockage during the healing process post-treatment.

Another important application segment is lithotripsy, which involves the non-invasive fragmentation of kidney stones using shock waves or laser technology. Ureteral stents are commonly used before and after lithotripsy procedures to aid in the passage of stone fragments and alleviate discomfort for the patient. The increasing adoption of minimally invasive procedures like lithotripsy is expected to fuel the demand for ureteral stents in the coming years.

Percutaneous nephrolithotomy (PCNL) is another significant application segment driving the demand for ureteral stents. PCNL is a minimally invasive procedure used to remove large or complex kidney stones. Ureteral stents are often placed during PCNL to facilitate urine drainage and prevent complications such as ureteral injury or postoperative obstruction. The growing prevalence of kidney stones and the rising preference for minimally invasive treatment options are expected to drive the demand for ureteral stents in PCNL procedures.

Kidney transplantation represents another important application segment for ureteral stents. During a kidney transplant surgery, ureteral stents are used to ensure the proper drainage of urine from the transplanted kidney to the bladder. These stents help prevent complications such as ureteral leakage or obstruction, which can occur following transplantation. With the increasing number of kidney transplant procedures performed globally, the demand for ureteral stents in this application segment is expected to rise.

Global Ureteral Stents Market, Segmentation by End Users

The Global Ureteral Stents Market has been segmented by End Users into Hospitals, Clinics and Ambulatory Surgical Centers.

Hospitals represent the largest segment among the end users of ureteral stents. This can be attributed to several factors, including the availability of advanced medical facilities, skilled healthcare professionals, and a higher patient footfall. Hospitals often serve as the primary point of contact for patients with urological issues, including kidney stones and ureteral strictures, necessitating the use of stents for management and relief of symptoms.

Clinics also constitute a significant portion of the end user segment for ureteral stents. These facilities, ranging from standalone urology clinics to multispecialty clinics, offer outpatient services for urological conditions. Clinics are preferred by patients seeking specialized care in a more convenient and personalized setting. They play a crucial role in diagnosing urological disorders, recommending treatment options, and providing follow-up care, including the placement and removal of ureteral stents.

Ambulatory surgical centers (ASCs) are emerging as key contributors to the ureteral stents market. These facilities are designed to provide same-day surgical procedures in a cost-effective and efficient manner. ASCs offer a convenient alternative to traditional hospital-based care, especially for elective procedures such as ureteral stent placement. With advancements in minimally invasive techniques, many urological procedures, including stent placement, can be safely performed in ASCs, leading to shorter recovery times and reduced healthcare costs.

Global Ureteral Stents Market, Segmentation by Geography

In this report, the Global Ureteral Stents Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Ureteral Stents Market Share (%), by Geographical Region, 2024

The North American region holds a prominent share in the global ureteral stents market owing to the presence of advanced healthcare infrastructure, high healthcare expenditure, and increasing prevalence of urological disorders in the region. Additionally, the rise in demand for minimally invasive procedures and the availability of innovative medical technologies further propel market growth in this region. The United States, in particular, contributes significantly to the market growth due to its large patient pool and well-established healthcare facilities.

Europe is another significant market for ureteral stents, driven by factors such as increasing awareness about urological disorders, favorable reimbursement policies, and the presence of leading medical device manufacturers. Countries like Germany, the UK, and France are major contributors to the market growth in this region. Moreover, ongoing advancements in healthcare infrastructure and rising healthcare expenditure continue to fuel the demand for ureteral stents across European countries.

The Asia Pacific region is witnessing rapid growth in the ureteral stents market due to factors such as a large population base, rising geriatric population, increasing prevalence of urological disorders, and improving healthcare infrastructure. Countries like China, India, and Japan are key markets in this region, supported by government initiatives aimed at improving healthcare facilities and rising disposable income levels, which enable patients to opt for advanced treatment options.

In the Middle East and Africa region, the market for ureteral stents is gradually expanding due to improving healthcare infrastructure, increasing awareness about urological disorders, and growing investments in the healthcare sector. However, the market growth in this region is relatively slower compared to other regions due to challenges such as limited access to healthcare facilities in remote areas and economic constraints.

Latin America also presents opportunities for market growth, driven by factors such as the increasing prevalence of urological disorders, improving healthcare infrastructure, and rising healthcare expenditure. Countries like Brazil and Mexico are major contributors to the market growth in this region. Moreover, strategic initiatives undertaken by market players to expand their presence in Latin American countries further contribute to market growth.

This report provides an in depth analysis of various factors that impact the dynamics of Global Ureteral Stents Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers

• Aging population
• Increasing urological disorders
• Technological advancements

• Growing awareness: The global ureteral stents market has been witnessing significant growth, largely driven by the increasing awareness about urinary tract disorders and the rising prevalence of urological diseases worldwide. Ureteral stents play a crucial role in the management of various urological conditions such as kidney stones, urinary strictures, and tumors. With advancements in medical technology and growing adoption of minimally invasive procedures, the demand for ureteral stents has surged among healthcare providers and patients alike. Moreover, the expanding geriatric population, which is more susceptible to urinary tract complications, has further fueled market growth.

  In addition to demographic factors, there has been a notable increase in public awareness campaigns and educational initiatives focusing on urinary health. These efforts aim to inform individuals about the symptoms, risk factors, and available treatment options for urinary tract disorders. As a result, more people are seeking medical advice at an early stage, leading to timely diagnosis and intervention. Consequently, the demand for ureteral stents as a temporary or permanent solution for urinary obstructions has seen a steady rise. Furthermore, healthcare providers are increasingly recommending preventive measures, including the use of stents, to manage recurrent urinary tract issues and improve patients' quality of life.

  The growing emphasis on patient-centric healthcare and the expanding access to medical services in emerging economies have also contributed to the uptake of ureteral stents. Governments and healthcare organizations are investing in infrastructure development and promoting awareness campaigns to address the unmet medical needs of the population. Additionally, collaborations between industry players and healthcare institutions for product development and distribution have bolstered market growth. Looking ahead, technological innovations, such as the development of biocompatible materials and drug-eluting stents, are expected to further drive the expansion of the global ureteral stents market, catering to the evolving needs of patients and healthcare providers.

Restraints

• Complications associated with stents
• Stringent regulatory requirements
• High cost of procedures

• Limited reimbursement policies: The global ureteral stents market has been experiencing significant growth, primarily driven by the rising prevalence of urinary tract disorders and an increasing number of minimally invasive procedures. Ureteral stents play a crucial role in the management of various urological conditions, such as kidney stones, ureteral strictures, and obstructive uropathy. However, one of the major challenges faced by the market is limited reimbursement policies, which can impede the adoption of these devices.

  Limited reimbursement policies pose a significant barrier to patients seeking treatment involving ureteral stents. Reimbursement policies vary across different regions and healthcare systems, and in some cases, the coverage for ureteral stents may not be comprehensive. This can result in higher out-of-pocket expenses for patients or reluctance among healthcare providers to recommend stent placement due to financial concerns.

  Limited reimbursement can also affect the profitability of manufacturers and suppliers in the ureteral stents market. Without adequate reimbursement, healthcare facilities may be hesitant to invest in advanced stent technologies or may opt for cheaper alternatives, impacting the revenue potential for companies operating in this space. Addressing reimbursement challenges requires collaboration between healthcare providers, payers, and policymakers to ensure equitable access to essential medical devices while maintaining fiscal sustainability in healthcare systems. Additionally, innovation in product design and manufacturing processes aimed at cost reduction could help mitigate the impact of limited reimbursement on market growth.

Opportunities

• Emerging markets expansion
• Innovative product developments
• Minimally invasive techniques

• Strategic collaborations and partnerships: The global ureteral stents market has witnessed significant growth in recent years, driven by strategic collaborations and partnerships among key players in the industry. These collaborations aim to leverage each company's strengths and resources to enhance product development, expand market reach, and improve patient outcomes. Through partnerships, companies can combine their expertise in medical device technology, research and development, and marketing to bring innovative solutions to the market more efficiently.

  One prominent trend in the ureteral stents market is collaborations between medical device manufacturers and healthcare providers. By working closely with urologists, hospitals, and clinics, manufacturers gain valuable insights into the evolving needs of patients and clinicians. This collaboration often leads to the development of stents that are more tailored to specific clinical scenarios, improving patient comfort and reducing complications. Additionally, partnerships with healthcare providers can facilitate clinical trials and real-world evidence generation, supporting regulatory approvals and reimbursement decisions.

  Strategic alliances between ureteral stent manufacturers and other stakeholders, such as pharmaceutical companies and research institutions, are driving innovation in materials science, drug-eluting technologies, and minimally invasive procedures. These partnerships enable companies to combine their expertise in biomaterials, drug delivery systems, and medical imaging to develop stents with enhanced biocompatibility, durability, and therapeutic capabilities. By pooling resources and sharing risks, partners can accelerate the pace of innovation and address unmet clinical needs in the management of urological disorders. Overall, strategic collaborations and partnerships play a vital role in shaping the future of the global ureteral stents market, driving innovation and improving patient care.

Key players in Global Ureteral Stents Market include:

• Boston Scientific Corporation
• Cook Medical Inc
• C. R. Bard, Inc
• Coloplast Corp
• Teleflex Incorporated
• Medtronic plc
• Olympus Corporation
• Allium Medical Solutions Ltd
• Pnn Medical A/S
• Applied Medical Resources Corporation

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis